High serum level of soluble CD30 in acute primary HIV-1 infection

Clinical and Experimental Immunology

Volumn 108, Issue 2, 1997, Pages 251-253

  Pizzolo, G ^a,c   Vinante, F ^a   Nadali, G ^a   Krampera, M ^a   Morosato, L ^a   Chilosi, M ^a   Raiteri, R ^b   Sinicco, A ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c OSPEDALE POLICLINICO   (Italy)

Author keywords

acute HIV 1 infection; CD30; soluble CD30

Indexed keywords

CD30 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS REPLICATION;

EID: 0030972716     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-1005.x     Document Type: Article

References (15)

1. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Ann Rev Immunol 1995; 13:487-512.
2. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373:117-22.
3. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
4. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995; 16:76-80.
5. + T cell clones in human immunodeficiency virus (HIV) infection. J Exp Med 1994; 180:2407-11.
6. + cells. Immunity 1995; 3:251-5.
7. Biswas P, Smith CA, Goletti D, Hardy EC, Jackson RW, Fauci AS. Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 1995; 2:587-96.
8. Falini B, Pileri S, Pizzolo G et al. CD30 (Ki-1) molecule: a new cytokine receptor of the TNF receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85:1-14.
9. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73:1349-60.
10. + T cells producing Th2-type cytokines. FASEB J 1995; 9:81-86.
11. Pizzolo G, Vinante F, Morosato L et al. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994; 8:741-5.
12. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type-2 T helper (Th2) responses. J Leuk Biol 1995; 57:726-30.
13. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV-1 to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265:244-8.
14. McDonald PP, Cassatella M, Bald A et al. CD30 ligation induces nuclear factor-B activation in human T cell lines. Eur J Immunol 1995; 25:2870-6.
15. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86:5974-8.